Cancer is 2nd only to heart disease as cause of premature death. Surgery and radiotherapy (RT) are thus far the only available tools for non-systemic curative treatment. 40% of the cured patients received RT. Still, 25 to 30% of them will die due to local failure related to radio-resistance. This problem could be overcome by using a new type of beam : light ions. Regional consortia in 5 EU countries are developing with robust national funding a clinical facility to deliver this treatment. Most of them will use the PIMMS accelerator developed by the CERN research centre. RTD in the clinical assessment (indications and trials), in a common beam delivery system, biological dose optimisation, PET on line for dose verification, treatment planning and cost-efficiency studies could be shared. A concerted approach to the industrial spin-offs will cut costs and reinforce Europe's health technology sector. This is the aim of ENLIGHT.
Funding SchemeTHN - Thematic network contracts
128 08 Praha 2
171 76 Stockholm
01314 Weissig - Dresden